The Valley Desk

ArticleVaccinesPublished

Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Vaccines
Published
Subject terms
Adenovirus Vaccine; Real-world Data; Booster Vaccine; Real-world Evidence; Covid-19
PubMed ID
40006713
PubMed Central ID
PMC11861575
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal